Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality.

Adeline LimAleksandar RadujkovicMarkus A WeigandUta Merle

Published in: Annals of intensive care (2021)

Serum sRAGE concentrations are elevated in COVID-19 patients as disease severity increases. sRAGE should be considered as a biomarker for predicting the need for MV and mortality in COVID-19.

Keyphrases

mechanical ventilation
sars cov
coronavirus disease
acute respiratory distress syndrome
intensive care unit
cardiovascular events
respiratory failure
extracorporeal membrane oxygenation
risk factors
respiratory syndrome coronavirus